The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and ...

AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 ...

A Dutch court on Thursday sentenced a former employee of semiconductor firms ASML and NXP to three years in prison for sharing sensitive company technology with a contact in Russia, in violation of ...

Under a new licensing deal announced July 8, JCR Pharmaceuticals Co. Ltd. granted Alexion Pharmaceuticals Inc. rights to its adeno-associated virus (AAV) capsids for use in up to five of Alexion’s ...

NBA free agency 2025: Live updates, news, rumors as Moe Wagner re-signs with Magic, Deandre Ayton reportedly agrees to terms with the Los Angeles Lakers ...

Every helpful hint and clue for Sunday's Strands game from the New York Times.